iOnctura – Talk Bio

Actionable Insights Powered by AI

iOnctura Secures €80 Million in Series B Financing to Advance Rare Eye Cancer Treatment

10 months ago talkbio0Tagged Cancer Therapeutic Procedure, Infrequent, iOnctura, Malignant tumor of eye, melanoma, roginolisib, Series B financing, Uvea

iOnctura, Series B financing, rare eye cancer, uveal melanoma, roginolisib, cancer treatment

Syncona Expands Portfolio with Investments in iOnctura and Yellowstone, Two Cancer-Focused Biotechs

10 months ago talkbio0Tagged Biotechnology, cancer biotechs, expansion, Investments, iOnctura, portfolio, Syncona, Yellowstone

Syncona, iOnctura, Yellowstone, cancer biotechs, portfolio expansion, investment, biotechnology